<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Zepbound on Guia GLP-1 — Ozempic, Wegovy, Mounjaro</title><link>https://glp1decode.com/pt/tags/zepbound/</link><description>Recent content in Zepbound on Guia GLP-1 — Ozempic, Wegovy, Mounjaro</description><image><title>Guia GLP-1 — Ozempic, Wegovy, Mounjaro</title><url>https://glp1decode.com/images/default-og.png</url><link>https://glp1decode.com/images/default-og.png</link></image><generator>Hugo</generator><language>pt</language><lastBuildDate>Sat, 04 Jul 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://glp1decode.com/pt/tags/zepbound/index.xml" rel="self" type="application/rss+xml"/><item><title>Zepbound para perda de peso: o que os ensaios clínicos realmente mostram</title><link>https://glp1decode.com/pt/posts/zepbound-tirzepatide-weight-loss-2026/</link><pubDate>Sat, 04 Jul 2026 00:00:00 +0000</pubDate><guid>https://glp1decode.com/pt/posts/zepbound-tirzepatide-weight-loss-2026/</guid><description>Zepbound (tirzepatida) é o mais novo agonista duplo GLP-1/GIP aprovado para perda de peso. Detalhamos os resultados dos ensaios SURMOUNT, resultados do mundo real, efeitos colaterais e como ele se compara ao Wegovy e Mounjaro.</description></item></channel></rss>